ERGO Share PerformanceMore
|52 week high||225.00 23/10/17|
|52 week low||128.20 21/11/16|
|52 week change||67.00 (52.34%)|
|4 week volume||1,128,130 24/10/17|
Latest News« previous» nextMore
23/10/2017 - 11:20 StockMarketWire
Numis today reaffirms its buy investment rating on Ergomed Plc (LON:ERGO) and raised its price target to 300p (from 2...
23/10/2017 - 08:51 StockMarketWire
Ergomed has announced positive top-line results from its phase II clinical trial of PeproStat, the company's potential first-in...
23/10/2017 - 06:00 RNS
Miscellaneous medium priority announcements
12/10/2017 - 15:48 RNS
Notification of major interests in shares
06/10/2017 - 10:00 StockMarketWire
Numis today reaffirms its buy investment rating on Ergomed Plc (LON:ERGO) and set its price target at 280p.
03/10/2017 - 06:38 StockMarketWire
Ergomed completed the acquisition of PSR Group BV following the admission to trading on AIM of the 2,081,389 new ordi...
03/10/2017 - 06:00 RNS
Statement regarding an acquisition of a company or assets
28/09/2017 - 13:31 StockMarketWire
Ergomed has confirmed that the Company has conditionally placed 1,757,576 new ordinary shares at 165p apiece, raising gr...
|Dividend yield||0 %|
Latest discussion posts More
“If you would like to hear management present the preliminary results for the year ended 31 December 2016 for Ergomed we will be hosting a webinar on Wednesday 29th March at ...”▼
“If you would like to hear Stephen Stamp, Chief Finance Officer, present on behalf of Ergomed he will be appearing at our next investor forum on the evening of Wednesday 25th of ...”▼
Codes & Symbols
|Symbols||ERGO, LSE:ERGO, ERGO.L, ERGO:LN, LON:ERGO, XLON:ERGO|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment